SCHEMBL23637142

SCHEMBL23637142

OCC1CC[C@H](n2cnc3c(Nc4ccc(OC(F)(F)F)cc4)ncnc32)O1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA1 P30542 1/20 0.51
▸ ABL1 P00519 5/20 0.48
▸ BCR P11274 5/20 0.48
▸ LMNA P02545 3/20 0.46
▸ ALDH1A1 P00352 2/20 0.46
▸ MAPK1 P28482 2/20 0.46
▸ GLA P06280 1/20 0.46
▸ PMP22 Q01453 1/20 0.46
▸ SMN1; SMN2 Q16637 1/20 0.46
▸ NPC1 O15118 1/20 0.46
▸ NPY1R P25929 1/20 0.46
▸ HTT P42858 1/20 0.46
▸ NPY2R P49146 1/20 0.46
▸ RAB9A P51151 1/20 0.46
▸ SLC29A1 Q99808 1/20 0.46
▸ RXFP1 Q9HBX9 1/20 0.46
▸ CYP1A2 P05177 1/20 0.46
▸ TSHR P16473 1/20 0.46
▸ NFKB1 P19838 1/20 0.46
▸ CYP2C19 P33261 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18696325 1.00 ADORA1 (0.51) ADORA1ABL1BCRLMNAALDH1A1
SCHEMBL13467412 0.88 NR2F2 (0.55) ABL1SMN1; SMN2NPC1RAB9ASLC29A1
SCHEMBL18696212 0.85 ABL1 (0.57) ABL1BCR
SCHEMBL20925387 0.84 ADORA1 (0.56) ADORA1LMNAALDH1A1GLAPMP22
SCHEMBL3395259 0.80 ADORA1 (0.78) ADORA1LMNAALDH1A1MAPK1GLA
SCHEMBL13820258 0.80 ADORA1 (0.78) ADORA1LMNAALDH1A1MAPK1GLA
SCHEMBL24390241 0.80 ADORA1 (0.78) ADORA1LMNAALDH1A1MAPK1GLA
SCHEMBL16609165 0.80 ADORA1 (0.78) ADORA1LMNAALDH1A1MAPK1GLA
SCHEMBL23982207 0.79 PRKAB2 (0.52) ABL1LMNAALDH1A1MAPK1GLA
SCHEMBL20419240 0.77 ALDH1A1 (0.57) ABL1LMNAALDH1A1MAPK1ALB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3536687-B1 SMALL MOLECULE MYRISTATE INHIBITORS OF BCR-ABL AND METHODS OF USE DANA FARBER CANCER INST INC (US) 2021-07-14 — — EP disclosed
Send feedback